Pharmaceutical Fraud a Growing Threat
- Drugs for pre-osteoporosis: prevention or disease mongering? Alonso-Coello, Pablo; García-Franco, Alberto López; Guyatt, Gordon; Moynihan, Ray // BMJ: British Medical Journal (International Edition);1/19/2008, Vol. 336 Issue 7636, p126
This article suggests that drugs used for the prevention of osteoporosis in women with slightly lowered bone mineral density may not have the effect that patients are hoping for. The marketing of the disease by drug companies and others portray it as an epidemic that brings misery to millions of...
- Doctored results. Kippen, A. // Washington Monthly;Oct90, Vol. 22 Issue 9, p38
Examines some of the shady practices going on between doctors, medical journals and drug companies. Surgical incentives; Pharmaceutical sales; Honoraria based on drug prescriptions; Drug company supplements in medical journals; Medical symposia.
- Wisconsin finds some price discrimination. // Drug Topics;8/7/95, Vol. 139 Issue 15, p7
Reports on a Wisconsin study which found evidence that some manufacturers and wholesalers may be granting illegal discounts to hospital and health maintenance organization (HMO) pharmacies.
- Full court press coming on short Rxs. // Drug Topics;2/16/98, Vol. 124 Issue 4, p7
Reports that there will be investigations on drugstores in the United States which charge full fees for short-filled prescriptions. Reference to a lawsuit in Florida filed against Eckerd; Identification of other companies involved in this practice.
- How R.Ph.s can avoid being taken in by scam artists. McCann, Jean // Drug Topics;2/16/98, Vol. 124 Issue 4, p80
Presents a look at how R.Ph.s can avoid being taken in by scam artists. Views from Ronald Buzzeo, a pharmacist-consultant who worked for the Drug Enforcement Administration for years, on scammers in search of controlled substances; Comments made by Buzzeo during the Second Conference on Pain...
- The other drug lords. // Common Cause Magazine;Fall92, Vol. 18 Issue 3, p8
Examines the power of the pharmaceutical industry and its lobbyists to control the fate of drug-related reforms and other legislation in Congress. Defeat of Arkansas Senator David Pryor's amendment to cut a tax break enjoyed by drug companies with factories in Puerto Rico; Price gouging; Drug...
- The other drug war here at home. // U.S. News & World Report;9/11/89, Vol. 107 Issue 10, p11
Discusses the battle between brand-name pharmaceutical companies and the generic-drug industry. Food and Drug Administration probe into generic-drug products; Scandal; Costs.
- Peddling data. Conlan, Michael F. // Drug Topics;10/10/94, Vol. 138 Issue 19, p103
Reports on the collection of product prescription information and drugstore pricing policies by software companies for sale to interest groups in the pharmaceutical industry.
- Prescription drug industry must be reformed. Pryor, David // USA Today Magazine;Mar94, Vol. 122 Issue 2586, p74
Argues for a reform in the pharmaceutical industry. High cost of prescription medications; Tax credits and tax break given to the pharmaceutical industry; Findings of a report by the American Association of Retired Persons (AARP); Report by the Senate Special Committee on Aging; Inability of...